Improving PKU Management
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
Jun 2023
Close 
News
Latest News
Jun 2023 Improving PKU Management Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
Companies join forces to introduce PKU GOLIKE Plus® 3-16, a breakthrough treatment for phenylketonuria (PKU), in the Middle East.
Read more
Sep 2023 NEW WODA MEMBER FOR AUSTRALIA, NEW ZEALAND AND SOUTHEAST ASIA World Orphan Drug Alliance Welcomes Specialised Therapeutics
Specialised Therapeutics to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA)
Read more